MODIFIED TREATMENT TOLERABILITY EVALUATION SCORE IN PATIENTS UNDERGOING TEMPORARY ANCHORAGE DEVICES (TAD) UNDER TOPICAL LIGNOCAINE AEROSOL 15% WITH LIGNOCAINE WITH OR WITHOUT ADRENALINE INFILTRATION DURING ORTHODONTIC TREATMENT

Authors

  • Shubhangi Mani PIMS (DU)
  • Nikita Darda PIMS (DU)
  • Toshniwal NG PIMS
  • Nilesh Mote PIMS
  • Vishal Dhanjani PIMS

Abstract

Introduction: This study was undertaken primarily to compare the efficacy and safety of topical Lignocaine aerosol 15%, Lignocaine 2% with or without Adrenaline (1:80000) used in Temporary Anchorage Devices (TAD) placement in Orthodontic Treatment. Method: The study population included all patients of both gender and aged above 12 years, who were scheduled for placement of Temporary Anchorage Devices (TAD) in orthodontic treatment, and willing to participate in the study were included in the study. Depending on the local anaesthetic used, the patients were divided into Group 1 (Topical Lignocaine Aerosol 15% USP + Lignocaine 2% with Adrenaline), Group 2 (Lignocaine 2%) and Group 3 (Lignocaine 2% with Adrenaline). All the groups were assessed for immediate adverse drug reactions.  The severity of adverse effects was graded by using Modified Treatment Tolerability Evaluation Score (MTTES) for the signs and symptoms Results: There was no statistically significant difference between age and gender of the three treatment groups.  MTTES score was lowest in Group 2 followed by Group 3. It was significantly higher in Group 1. Conclusion: Group 1 (topical and infiltration lignocaine) and 3 combinations showed higher MTTES score for the adverse effect profile, whereas Group 2 appeared safer in terms of both the variables. Thus, use of topical and infiltration lignocaine raises concerns regarding safety of this combination.

 

Downloads

Download data is not yet available.

Downloads

Published

2019-11-13

Issue

Volume 5, Issue 4; October 2019.

Section

Original Research Articles

License

The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.

The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.

What are my rights as an author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:

  • The journal allows the author(s) to hold the copyright without restrictions.
  • The journal allows the author(s) to obtain publishing rights without restrictions.
  • You may do whatever you wish with the version of the article you submitted to the journal.
  • Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
  • You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
  • You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.